Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06051448 · ClinicalTrials.gov registry record · Phase 1
Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD).
A Phase 1 study of Mitochondrial Diseases and MItochondrial Myopathies, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT06051448 is a Phase 1 study of Mitochondrial Diseases and MItochondrial Myopathies that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 16 participants, below the 274-participant average among 7 other Mitochondrial Diseases trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06051448, a Phase 1 study of Mitochondrial Diseases and MItochondrial Myopathies, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to find the best way to help people with primary mitochondrial disease deal with the stress of their condition, and to help these people be better able to "bounce back," or be resilient. In order to do this, the investigators are going to test two interventions (an intervention means that it aims to change something): Promoting Resilience in Stress Management (PRISM) and clinical-focused narrative (CFN) intervention.
Conditions Studied
Interventions
- BEHAVIORAL Promoting Resilience in Stress Management (PRISM)
- BEHAVIORAL Clinical-focused narrative (CFN)
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-09-22 |
| Est. Completion | 2024-02-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06051448
The ClinicalTrials.gov registry entry for NCT06051448 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 274-participant average among 7 other Mitochondrial Diseases trials with a reported enrollment target (94% lower). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Mitochondrial Diseases appearing as the primary indexed condition, and to 2 interventions - of which Promoting Resilience in Stress Management (PRISM) is the first listed.
NCT06051448 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06051448 about?
NCT06051448 is a clinical study titled "Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD).". The goal of this study is to find the best way to help people with primary mitochondrial disease deal with the stress of their condition, and to help these people be better able to "bounce back," or be resilient. In order to do this, the investigators are going to test two interventions (an interven...
What is the current status of trial NCT06051448?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2023-09-22. Estimated completion is 2024-02-28.
What conditions does trial NCT06051448 study?
This clinical trial studies the following conditions: Mitochondrial Diseases, MItochondrial Myopathies, Mitochondrial Encephalomyopathies, MELAS, MERRF.
What interventions are being tested in trial NCT06051448?
The interventions under investigation include: Promoting Resilience in Stress Management (PRISM) (BEHAVIORAL), Clinical-focused narrative (CFN) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06051448?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06051448 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitochondrial Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Validation of Oxygen Nanosensor in Mitochondrial Myopathy
RECRUITING · Phase 1
-
Applying pGz in Mitochondrial Disease
RECRUITING · Phase 1
-
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
RECRUITING
-
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
RECRUITING · Phase 3
-
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
RECRUITING
-
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.